The post APT Weekly Analysis Feb 3 appeared on BitcoinEthereumNews.com. APT, despite its limited weekly rise of 0.71%, is consolidating in a narrow range ($1.25The post APT Weekly Analysis Feb 3 appeared on BitcoinEthereumNews.com. APT, despite its limited weekly rise of 0.71%, is consolidating in a narrow range ($1.25

APT Weekly Analysis Feb 3

4 min read

APT, despite its limited weekly rise of 0.71%, is consolidating in a narrow range ($1.25-$1.30) within the main downtrend; although RSI 30.85 gives an oversold signal, the risk of deep correction increases if $1.14 support breaks.

Weekly Market Summary for APT

APT closed the week at the current $1.27 level with a 0.71% increase, but in the broader market context, it remains in a cautious position for altcoins under Bitcoin’s downtrend dominance. The weekly trading range is stuck between $1.25-$1.30, volume profile remained low at $55.22M, raising the question of accumulation or distribution. Market structure continues to remain bearish below EMA20 ($1.50); MACD negative histogram confirms momentum decline. Long-term downtrend filters are active, recovery will remain limited without breaking $1.61 resistance. This week, multi-timeframe confluences highlight the critical support at $1.1410 (77/100 score), this is the inflection point that will determine the trend’s fate.

Trend Structure and Market Phases

Long-Term Trend Analysis

The long-term trend structure exhibits a clear downtrend character; higher highs/higher lows structure is broken on weekly and monthly charts. While the primary trend is defined as bearish, price continues to stay below EMA20 ($1.50) and EMA50. This signals the continuation of the distribution phase – especially after rejection at $1.61. In the market cycle context, APT has experienced nearly 80% correction from 2025 highs and currently has potential to approach cycle lows. The trend remains solid as long as price holds $1.1410 support; in case of breakdown, it could gain momentum toward $0.4596 downside target (22 score). In macro context, rising Bitcoin dominance delays altcoin rotation.

Accumulation/Distribution Analysis

Volume profile at low levels ($55.22M) and price range contraction may be starting to show accumulation phase characteristics – RSI 30.85 in oversold region with divergence potential. However, as MACD bearish histogram widens, distribution patterns are emerging: selling pressure visible around upper range $1.30. According to Wyckoff methodology, this could be a secondary test phase; if spring test around $1.25 succeeds, accumulation strengthens. Distribution risk increases with rejection at $1.2893 resistance. Overall, market phase is a ‘re-accumulation’ attempt but downtrend filters dominate.

Multi-Timeframe Confluence

Daily Chart View

On the daily chart, 1S/2R confluence: support $1.1410 (77 score) strong, resistances $1.2893 (63) and $1.3845 (60). Price below EMA20, short-term bearish; RSI divergence signals bounce but MACD crossover on hold. Market structure with lower highs keeps downtrend intact; if $1.25 support breaks, daily bearish acceleration.

Weekly Chart View

On weekly, 1S/2R structure dominant: $1.1410 major support, $1.61 main resistance. Weekly candle doji-like, showing indecision; Supertrend bearish filter active. Price below long-term EMAs, in test phase for accumulation – confluence supports with 9 strong levels (1D/3D/1W breakdown). For trend change, weekly close above $1.3845 required.

Critical Decision Points

Key levels will define direction: Support $1.1410 (77 score, multi-TF confluence), breakdown opens $0.4596 risk. Resistance $1.2893 (63), then $1.3845 (60) – breakout opens path to $1.8864 upside objective (6 score). $1.61 psychological barrier for downtrend breakdown. Watch: Volume spikes and BTC movements.

Weekly Strategy Recommendation

In Bullish Case

Bullish scenario: Long position with daily close above $1.2893, targets $1.3845 / $1.8864. Stop-loss below $1.1410; R/R 1:3+ strategic. Volume increase required for accumulation confirmation, BTC above $79k supportive. For position traders, scale-in on $1.25 rebound.

In Bearish Case

Bearish scenario: $1.1410 breakdown short trigger, target $0.4596. Stop above $1.2893; high R/R. Weekly close below for distribution confirmation. Altcoin caution mode, monitor BTC dominance.

Bitcoin Correlation

APT highly correlated with BTC (0.85+); BTC in downtrend at $78,459, supports $77,615/$74,604 critical. If BTC fails to break $79,295 resistance, altcoin pressure increases – Supertrend bearish BTC dominance pulls APT down. BTC breakdown below $74k accelerates APT $1.14 test; above $81k offers rotation opportunity. Key BTC levels: Watch $77k support and $79k resistance.

Conclusion: Key Points for Next Week

Next week focus: $1.1410 support test and $1.2893 resistance reaction. BTC below $77k risks altcoin dump; RSI bounce + volume confluence for bullish flip. Follow detailed APT spot analysis and APT futures market data. Strategic patience: Trend down, wait for inflection. Follow updates for APT and other analyses.

This analysis uses Chief Analyst Devrim Cacal’s market views and methodology.

Strategy Analyst: David Kim

Macro market analysis and portfolio management

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/apt-technical-analysis-february-3-2026-weekly-strategy

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29